KIT and metastatic neoplasm: In conclusion, we found that clinicopathologic factors such as after TKI treatment, large tumor size, high mitotic count, high Ki-67 index, high cellularity, presence of tumor necrosis, primary mutation in KIT exon11, and metastatic tumor lesions were associated with a higher success rate of PDX establishment.